Literature DB >> 14572393

[Differential health and toxicological features of drug-dependents in treatment and in active consumption].

C Navarro Cañadas1, P Bachiller Luque, T Palacios Martín, P Ruiz Muñoz, M Herrero Baladrón, I Sánchez Lite.   

Abstract

OBJECTIVES: To describe and compare the demographic and health characteristics and drug use patterns in a group of drug dependent individuals who were actively using drugs versus those in different types of treatment. To analyze the interventions used with the different groups.
DESIGN: Descriptive study.
SETTING: Users at the Association for Aid to Drug Dependent Persons (Asociación de Ayuda al Drogodependiente, ACLAD) in the city of Valladolid in northwestern Spain. PATIENTS: 1224 drug dependent persons. MEASURES: We reviewed the medical records for a 30-month period for users who were seen at a treatment center and who were participating in a damage reduction program. We recorded demographic, drug use and clinical variables and compared changes.
RESULTS: We studied 1224 patients in all. One-third had human immunodeficiency virus infection, 63% had markers for previous hepatitis A infection, 48% had markers for hepatitis B, and 68.5% for hepatitis C. The Mantoux test was positive in 39.1%. We found differences in the prevalence of infections between active drug users and users in treatment, between drug dependent persons receiving different types of treatment, and between different periods of study.
CONCLUSIONS: There were clear differences in demographic and health characteristics and drug use patterns between users. Those who were not in rehabilitation were in worse health, and were studied in less detail that other groups of drug users. During follow-up we noted a slight improvement in their health conditions, along with a tendency toward improved primary care interventions.

Entities:  

Mesh:

Year:  2003        PMID: 14572393      PMCID: PMC7684399          DOI: 10.1016/s0212-6567(03)79290-7

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  10 in total

1.  [Prevalence of HIV infection and risk behavior among drug users].

Authors:  P Bachiller Luque; C Navarro Cañadas; P Muñoz Núñez; A A Alvarez Hurtado
Journal:  Med Clin (Barc)       Date:  2000-04-29       Impact factor: 1.725

2.  [Intravenous drug dependence: a public health problem in Spain].

Authors:  J C March Cerdá; R Ballesta; E Pepsa
Journal:  Aten Primaria       Date:  2001-12       Impact factor: 1.137

3.  [Drug dependency and primary care: a relationship that can be set on course again?].

Authors:  J Zarco Montejo
Journal:  Aten Primaria       Date:  2001-11-15       Impact factor: 1.137

4.  [Risk behaviours among intravenous drug users under methadone treatment].

Authors:  K Pérez; A Rodés ; M Meroño ; J Casabona
Journal:  Med Clin (Barc)       Date:  2001-03-03       Impact factor: 1.725

5.  [Prevalence of anti-HAV antibodies and efficacy of pre-vaccine detection at institutions for mentally retarded of the city of Alicante].

Authors:  F Martínez-Campillo; M Terán; M Alvarez; M V Rigo; J Roda; M Salinas; J M García
Journal:  Aten Primaria       Date:  2000-05-15       Impact factor: 1.137

6.  [The prevalence of human immunodeficiency virus infection and the risk behaviors in the heroin addicts of Barcelona, Madrid and Seville: an example of the advantages of centering studies on addicts and not just on intravenous users].

Authors:  L de la Fuente; M J Bravo; C Lew; G Barrio; V Soriano; L Royuela
Journal:  Med Clin (Barc)       Date:  1999-11-20       Impact factor: 1.725

7.  [Consensus on care for the users of the Maintenance Program with Methadone at the health centers of the province of Cádiz].

Authors:  B Lahoz Rallo; G Moratalla Rodríguez; C Lineros; C Barros Rubio
Journal:  Aten Primaria       Date:  2000-04-15       Impact factor: 1.137

8.  [The Methadone Maintenance Program for intravenous heroin addicts. What information do primary care physicians have?].

Authors:  C Velarde Mayol; J Peinó Andión; J A Gómez de Caso Canto
Journal:  Aten Primaria       Date:  1996-05-31       Impact factor: 1.137

9.  [Prevalence of chronic hidden infections in a cohort of patients in substitutive treatment with methadone].

Authors:  J Portilla; J Esteban; R Llinares; J Belda; J Sánchez-Payá; M Isabel Manso; G de Estudio Protocolo-INH
Journal:  Med Clin (Barc)       Date:  2001-03-10       Impact factor: 1.725

10.  [Risk of tuberculosis in parenteral drug addicts with human immunodeficiency virus seropositivity. A cohort study in detoxication communities].

Authors:  J Solera; E López; E Serna; L Vergara; E Martínez-Alfaro; L Sáez
Journal:  Med Clin (Barc)       Date:  1993-05-15       Impact factor: 1.725

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.